Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China · Delayed Price · Currency is CNY 4.720
-0.210 (-4.26%)
Nov 13, 2026, 3:00 PM CST
SHA:600488 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,543 | 2,908 | 3,215 | 3,783 | 3,689 | 3,749 |
Revenue Growth | -11.45% | -9.56% | -15.00% | 2.54% | -1.59% | 20.27% |
Gross Profit Gross Profit Growth | 913.12 | 1,103 | 1,419 | 1,704 | 1,756 | 1,732 |
Operating Income Operating Income Growth | 107.44 | 207.69 | 269.96 | 179.93 | 181.37 | 178.2 |
Net Income Net Income Growth | 47.11 | 70.56 | 133.45 | 117.05 | 35.41 | 48.67 |
Earnings Per Share EPS Growth | 0.04 | 0.07 | 0.12 | 0.11 | 0.03 | 0.04 |
EPS Growth | 201.56% | -46.72% | 14.02% | 234.38% | -28.89% | 45.16% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Export Export Growth | 939.97 |
Southern China Southern China Growth | 786.3 |
North China North China Growth | 373.21 |
East China East China Growth | 790.77 |
Total Total Growth | 2,890 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 719.01 | 824.6 | 638.46 | 718.86 | 647.74 | 232.22 |
Total Debt Total Debt Growth | 641.55 | 735.67 | 533.66 | 951.96 | 1,403 | 1,407 |
Net Cash (Debt) Net Cash Growth | 77.45 | 88.93 | 104.8 | -233.1 | -755.57 | -1,175 |
Net Cash Growth | - | -15.14% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.07 | 0.08 | 0.10 | -0.21 | -0.68 | -1.09 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 397.68 | 136.48 | 569.37 | 783.01 | 653.52 | 316.89 |
Capital Expenditures CapEx Growth | -41.52 | -55.91 | -77.74 | -133.15 | -202.2 | -370.84 |
Free Cash Flow Free Cash Flow Growth | 356.17 | 80.57 | 491.63 | 649.86 | 451.33 | -53.95 |
Free Cash Flow Growth | 323.36% | -83.61% | -24.35% | 43.99% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.90% | 37.93% | 44.13% | 45.04% | 47.61% | 46.21% |
Operating Margin | 4.23% | 7.14% | 8.40% | 4.76% | 4.92% | 4.75% |
Pretax Margin | 3.04% | 4.20% | 7.04% | 4.45% | 0.34% | 3.98% |
Profit Margin | 1.85% | 2.43% | 4.15% | 3.09% | 0.96% | 1.30% |
FCF Margin | 14.00% | 2.77% | 15.29% | 17.18% | 12.23% | -1.44% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.052 | 0.052 | 0.098 | 0.087 | 0.010 | 0.014 |
Dividend Per Share Growth | -46.94% | -46.94% | 12.64% | 770.00% | -28.57% | 40.00% |
Dividend Yield | 1.10% | 1.27% | 2.31% | 1.78% | 0.23% | 0.30% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 108.05 | 63.29 | 34.69 | 45.79 | 136.56 | 103.78 |
Forward PE | - | 70.80 | 70.80 | 70.80 | 70.80 | 70.80 |
P/FCF Ratio | 14.75 | 55.43 | 9.42 | 8.25 | 10.71 | - |
PS Ratio | 2.07 | 1.54 | 1.44 | 1.42 | 1.31 | 1.35 |